Tuberculosis - I.T. Pyatnochka 2005

Pulmonary tuberculosis combined with other conditions and pregnancy
Tuberculosis and peptic ulcer disease of the stomach and duodenum

The incidence of tuberculosis among patients with gastric and duodenal ulcers is 6–9 times higher, whereas the reverse sequence of these conditions occurs 2–4 times more frequently than in the general population. This comorbidity is most commonly observed in men aged 30–50 years.

Pathogenesis. Pulmonary Tuberculosis in most patients develops several years after the onset of PEPTIC ULCER DISEASE or following gastric resection. Contributing factors include Cerebral Cortex dysfunction, neurohumoral disorders, digestive disturbances, and inadequate Nutrition, which lead to metabolic abnormalities and lowered body resistance. However, in a subset of patients, tuberculosis precedes The Development of peptic ulcer disease.

The pathological anatomy of tuberculosis encompasses various forms, with fibro-cavernous pulmonary tuberculosis being the predominant presentation.

The clinical manifestations of comorbid conditions are quite diverse, driven by the developmental pattern of both diseases. Generally, when tuberculosis develops against the Background of a gastric or duodenal ulcer, its course is more severe, accompanied by intense pain, dyspeptic symptoms, and impaired gastric acid-secretion and motility. In patients whose peptic ulcer disease develops secondary to tuberculosis, ulcer symptoms are significantly milder and are frequently masked by dyspeptic disorders caused by the Adverse effects of anti-tuberculosis drugs.

Diagnosis of tuberculosis relies on conventional Methods. Patients with gastric and duodenal ulcers, as well as those who have undergone gastric resection, constitute a high-risk group for tuberculosis and therefore require annual fluoroscopic screening.

The Treatment of pulmonary tuberculosis concurrent with gastric or duodenal ulcers is frequently complicated by adverse toxic dyspeptic reactions to anti-tuberculosis drugs; consequently, The Use of pyrazinamide, ethionamide, PAS, and thioacetazone is discouraged. Successful Tuberculosis Treatment necessitates, first and foremost, resolving the exacerbation of the ulcer process through anti-ulcer and general supportive therapy. To minimize irritant effects on the gastric mucosa, parenteral administration of drugs (intravenous, intramuscular, or intratracheal) is indicated. When clinically warranted, surgical management of both tuberculosis and peptic ulcer disease is employed, provided that mandatory antimycobacterial therapy is administered.